Growth of top pharma markets worldwide 2013-2020

In 2020, the growth rate of Brazil’s pharmaceutical market stood at 12.1 percent, which was a significant increase compared to the year before and the highest growth among leading national pharmacetical markets.

Pharma companies in Brazil

ACHE, which is a Brazilian-owned corporation founded in 1966, was the leading pharmaceutical company in Brazil in 2019, with a revenue of roughly 4.24 billion Brazilian reals (just over one billion U.S. dollars). Around half of the top ten companies were domestic and included enterprises, such as Neo Quimica, Libbs, and Mantecorp Farmasa.

Pharmaceutical R&D

Global pharmaceutical research and development expenditures in 2020 came to a total of 188 billion U.S. dollars. By 2026, R&D spending is expected to exceed 230 billion U.S. dollars, with pharmaceutical companies Roche and Merck & Co. spending a projected amount of 13 and 11 billion U.S. dollars that year, respectively.

Growth rate of top 10 national pharmaceutical markets worldwide from 2013 to 2020*

Characteristic	2013	2014	2015	2016	2017	2018	2019	2020**
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2020

More information

Region

Worldwide

Survey time period

2013 to 2020

Supplementary notes

* Prices are reported at the ex-manufacturer level (price when sold from manufacturer to wholesaler or direct to pharmacies).
Values not included in the current report were taken from previous IQVIA data.
** Values for 2020 are actually MAT December 2020. Values for China are hospital market only; values for Brazil are pharmacy market only.
*** In 2020 referred to as United Kingdom.

Open this statistic in...

German

Spanish